Clinical Trial Update: TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for TST001 in CLDN18.2-positive biliary tract cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Neoplasms

Drugs mentioned

• TST001

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Biliary Tract Neoplasms | Phase 2 | Status: COMPLETED